New web tool helps cancer patients alert relatives about genetic risks
NCT ID NCT05552664
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tested a web-based program called GIFT that helps cancer patients share information about inherited cancer risks with their relatives. Over 3,000 patients and their family members took part. The goal was to see if the tool encourages more relatives to get genetic testing and talk to their doctors about cancer prevention.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- web-based family communication program
- What this could lead to
- If successful, this approach could help more families learn about their inherited cancer risks and take steps to prevent or catch cancer early.
- What could go wrong
- This study is observational and does not test a new treatment. The results may not apply to all families or cancer types, and the impact on actual cancer outcomes is unknown.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
3,002 people
The number who actually took part.
- Started
-
Oct 2022
- Finished
-
Aug 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion criteria for the PICS survey are: 1. diagnosed with any cancer at any stage in 2018-2019 and reported to the Georgia or California SEER registries 2. Been found to carry a pathogenic variant (PV) in one of 27 cancer susceptibility genes (see Table 4) according to the Georgia California Genetic Testing Linkage Initiative dataset 3. aged 18 or older 4. alive at the time of selection as determined through linkage with Georgia and California vital statistics data. Additional eligibility criteria for Patient Trial Invitation will be evaluated from patient response to the PICS survey and will include patient report of: 1. Receipt of genetic testing for cancer risk 2. A positive test result (pathogenic variant; PV) Inclusion criteria for Relative Trial Invitation are assessed via patient report: 1. first-degree (biological parent, sibling, or biological child) or second-degree (biological half-sibling, aunt, uncle, nephew, niece, grandparent, or grandchild) relative of a patient enrolled in the study; 2. aged 18 or older; 3. alive at the time of study invitation; 4. relative lives in the United States or Canada (countries in which Color genetic testing is available, most people speak either English or Spanish, and test kit shipping costs are not exorbitant) Additional eligibility criteria for Relative Trial Enrollment will be evaluated from relative response to the relative eligibility screening survey (see Appendix C) and will include: 1. confirmation from the relative that they have not received clinical genetic testing ordered by a doctor or genetic counselor within the past five years (proxy for having already been tested for the PV carried by the patient who invited them into the study); 2. confirmation of age 18 or older; 3. confirmation of first-degree (biological parent, sibling, or biological child) or second-degree (biological half-sibling, aunt, uncle, nephew, niece, grandparent, or grandchild) relation to the patient. 4. confirmation of residence in United States or Canada Exclusion Criteria Exclusion criteria for the PICS survey are: 1\) Age\<18 Additional exclusion criteria for Patient Trial Invitation: 1. Patients who do not report receipt of genetic testing 2. Patients who do not report a positive genetic test result (PV) Exclusion criteria for Relative Trial Invitation are: 1. Age\<18 2. Relative does not live in the United States or Canada Additional exclusion criteria for Relative Trial Enrollment include relative report of: 1. Age\<18; 2. Receipt of genetic testing ordered by a doctor or genetic counselor within the past five years; 3. Relationship to proband (inviting) patient other than first- or second-degree relative 4. Residence in a country other than United States or Canada
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cancer are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Emory University
Atlanta, Georgia, 30322, United States
-
Stanford University
Stanford, California, 94305, United States
-
University of Michigan Rogel Cancer Center
Ann Arbor, Michigan, 48108, United States
-
University of Southern California
Los Angeles, California, 90007, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Évaluation de la détresse post-traumatique relative au cancer dans l'année suivant le diagnostic chez les patients et les aidants et identification de leurs attentes envers un accompagnement personnalisé
- Development and pilot implementation of a novel remote patient monitoring program for cancer patients initiating cancer-directed therapy: the SHIELD (Smart health integration for early life-saving detection)
- The promoting resilience in stress Management-Social needs (PRISM-SN) intervention for adolescents and young adults with cancer: a randomized controlled trial
- An equity focused intervention to improve utilization of guideline concordant extended venous thromboembolism prophylaxis after major cancer surgery
- The effect of gamified sleep hygiene education on sleep quality and fatigue levels in chemotherapy patients
- Can 10 minutes of breathing ease Chemotherapy's toll?